Image may be NSFW.
Clik here to view.
Tandem Diabetes Care (NSDQ:TNDM) has priced an underwritten public offering of 30 million shares of common stock at $2.00 apiece.
The San Diego, Calif.-based company said it expects to reel in $60 million from the offering. Tandem also gave underwriters a 30-day option to buy up to 4.5 million more shares of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem Diabetes Care prices $60m offering appeared first on MassDevice.
